Literature DB >> 15548579

EDEN-BP-dependent post-transcriptional regulation of gene expression in Xenopus somitic segmentation.

Carole Gautier-Courteille1, Christophe Le Clainche, Carine Barreau, Yann Audic, Antoine Graindorge, Dominique Maniey, H Beverley Osborne, Luc Paillard.   

Abstract

EDEN-BP is a Xenopus RNA-binding protein that triggers deadenylation [poly(A) tail shortening], and thereby translational repression and degradation, of a subset of maternal mRNAs soon after fertilization. We show here that this factor is expressed in the presomitic mesoderm of older embryos, the site where somitic segmentation takes place. Inhibiting EDEN-BP function using either antisense morpholino oligonucleotides or neutralizing antibodies leads to severe defects in somitic segmentation, but not myotomal differentiation. This is associated with defects in the expression of segmentation markers belonging to the Notch signalling pathway in the presomitic mesoderm. We show by a combination of approaches that the mRNA encoding XSu(H), a protein that plays a central role in Notch signalling, is regulated by the EDEN-BP pathway. Accordingly, XSu(H) is overexpressed in EDEN-BP knock-down embryos, and overexpressing XSu(H) causes segmentation defects. We finally give data indicating that, in addition to XSu(H), other segmentation RNAs are a target for EDEN-BP. These results show that EDEN-BP-dependent post-transcriptional regulation of gene expression is required for the process of somitic segmentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548579     DOI: 10.1242/dev.01528

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  23 in total

Review 1.  Reverse genetics in eukaryotes.

Authors:  Serge Hardy; Vincent Legagneux; Yann Audic; Luc Paillard
Journal:  Biol Cell       Date:  2010-10       Impact factor: 4.458

2.  Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter.

Authors:  James D Mills; Jieqiong Chen; Woojin S Kim; Paul D Waters; Avanita S Prabowo; Eleonora Aronica; Glenda M Halliday; Michael Janitz
Journal:  Neurogenetics       Date:  2015-03-29       Impact factor: 2.660

3.  Perspectives on the ARE as it turns 25 years old.

Authors:  Daniel Beisang; Paul R Bohjanen
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-06-25       Impact factor: 9.957

Review 4.  The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins.

Authors:  Twishasri Dasgupta; Andrea N Ladd
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-08-17       Impact factor: 9.957

Review 5.  The Maternal-to-Zygotic Transition During Vertebrate Development: A Model for Reprogramming.

Authors:  Valeria Yartseva; Antonio J Giraldez
Journal:  Curr Top Dev Biol       Date:  2015-08-13       Impact factor: 4.897

6.  Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice.

Authors:  Chantal Kress; Carole Gautier-Courteille; H Beverley Osborne; Charles Babinet; Luc Paillard
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

Review 7.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

8.  A strategy to analyze the phenotypic consequences of inhibiting the association of an RNA-binding protein with a specific RNA.

Authors:  Marie Cibois; Carole Gautier-Courteille; Audrey Vallée; Luc Paillard
Journal:  RNA       Date:  2009-11-23       Impact factor: 4.942

Review 9.  RNA-binding proteins in eye development and disease: implication of conserved RNA granule components.

Authors:  Soma Dash; Archana D Siddam; Carrie E Barnum; Sarath Chandra Janga; Salil A Lachke
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-01       Impact factor: 9.957

10.  CUG-BP, Elav-like family member 1 (CELF1) is required for normal myofibrillogenesis, morphogenesis, and contractile function in the embryonic heart.

Authors:  Yotam Blech-Hermoni; Connor B Sullivan; Michael W Jenkins; Oliver Wessely; Andrea N Ladd
Journal:  Dev Dyn       Date:  2016-05-31       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.